(NYSE: RVTY) Revvity's forecast annual revenue growth rate of 3.66% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.64%.
Revvity's revenue in 2025 is $2,798,467,000.On average, 6 Wall Street analysts forecast RVTY's revenue for 2025 to be $330,679,521,380, with the lowest RVTY revenue forecast at $329,635,680,668, and the highest RVTY revenue forecast at $331,492,841,948. On average, 6 Wall Street analysts forecast RVTY's revenue for 2026 to be $346,011,200,254, with the lowest RVTY revenue forecast at $343,888,232,766, and the highest RVTY revenue forecast at $349,699,986,847.
In 2027, RVTY is forecast to generate $371,208,235,921 in revenue, with the lowest revenue forecast at $367,944,274,971 and the highest revenue forecast at $378,130,804,592.